Biotricity (BTCY) Stock Price, News & Analysis

Company Overview

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

Key Stats

• Today's Range: $0.47 to $0.60
• 50-Day Range: $0.31 to $0.55
• 52-Week Range: $0.19 to $1.19
• Volume: 25,365 shs
• Average Volume: 35,323 shs
• Market Capitalization: $11.82 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BTCY Stock Analysis - Frequently Asked Questions

How have BTCY shares performed this year?

Biotricity's stock was trading at $0.2899 on January 1st, 2025. Since then, BTCY stock has increased by 63.7% and is now trading at $0.4746.
View the best growth stocks for 2025 here.

How were Biotricity's earnings last quarter?

Biotricity, Inc. (OTCMKTS:BTCY) announced its quarterly earnings results on Wednesday, February, 19th. The company reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.11) by $0.06. The firm had revenue of $3.62 million for the quarter, compared to the consensus estimate of $3.30 million.
Read the conference call transcript.

When did Biotricity's stock split?

Shares of Biotricity reverse split before market open on Monday, July 3rd 2023. The 1-6 reverse split was announced on Monday, July 3rd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, July 3rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split.

How do I buy shares of Biotricity?

Shares of BTCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Biotricity own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Biotricity investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Broadcom (AVGO), Micron Technology (MU) and Bank of America (BAC).

Company Calendar

• Last Earnings: 2/19/2025
• Today: 6/03/2025
• Fiscal Year End: 3/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:BTCY
• CIK: 1630113
• Web: www.biotricity.com
• Phone: (650) 832-1626
• Fax: N/A
• Employees: 40
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($1.08)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$18.66 million
• Net Margins: -163.11%
• Pretax Margin: -163.11%
• Return on Equity: N/A
• Return on Assets: -252.90%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.29
• Quick Ratio: 0.14

Sales & Book Value

• Annual Sales: $12.06 million
• Price / Sales: 0.98
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($2.67) per share
• Price / Book: -0.18

Miscellaneous

• Outstanding Shares: 24,912,000
• Free Float: 6,963,000
• Market Cap: $11.82 million
• Optionable: Not Optionable
• Beta: 1.22